2.6035
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 2.6035 | 07:17:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.6035 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.60 | 2.61 | 0.01 | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.6035 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.48B | 569.32M | 302.11M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 26.70M | $ - | 0.00% | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.71 | 2.72 | 2.31 | 2.53 | 1,984,001 | -0.1065 | -3.93% |
| 1 Month | 2.40 | 2.81 | 1.63 | 2.38 | 3,059,572 | 0.2035 | 8.48% |
| 3 Months | 3.48 | 5.15 | 1.63 | 3.11 | 3,317,915 | -0.8765 | -25.19% |
| 6 Months | 3.15 | 10.01 | 1.63 | 4.39 | 5,596,996 | -0.5465 | -17.35% |
| 1 Year | 0.314 | 10.01 | 0.261 | 3.30 | 5,374,238 | 2.29 | 729.14% |
| 3 Years | 0.61 | 10.01 | 0.0552 | 2.94 | 2,069,822 | 1.99 | 326.8% |
| 5 Years | 0.88 | 10.01 | 0.0552 | 2.79 | 1,333,897 | 1.72 | 195.85% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
